When it comes to sourcing medicines for Acute Myeloid Leukemia (AML), a supply partner with experience is imperative. At CSI, we’ve built a reputation as a world leader in delivering reliable and timely supply solutions that help drive AML studies forward. Our expertise spans across numerous global AML programs, partnering with leading pharmaceutical and biotech companies to ensure that clinical trials are never delayed due to supply chain challenges. With direct manufacturer